11. History :
• CUZACK (1827)- First Recognized
• FALKSON (1879) – Description
• MALASSEZ (1885) – Admantinoma
• IVY &CHURCHILL (1934) – Ameloblastoma
• Unicystic ameloblastoma – Robinson and
Martinez in 1977
12. ORIGIN
• Cell rests of enamel organ
– Dental lamina remnants
– Hertwig’s sheath
– Rests of malassez
• Epithelium of Odontogenic cysts (Dentigerous cyst &
Odontomas)
• Disturbances in developing enamel organ.
• Heterotropic epithelium in other parts of the body,
especially the Pituitary Gland.
• Basal cells of oral epithelium.
19. Classification
Robinson and Martinez 1977
Anatomic site
1. Central /intraosseous
i. Multicystic/Conventional
ii. Unicystic
iii.solid
2. Peripheral/ extra osseous
20. Radiological features
• Numerous well defined radioluscency of varying
diameter
• Honey comb
• Soap bubble appearance
• Unicystic radiolucent lesion indistinguishable
with cysts
35. Unicystic ameloblastoma
Ackerman in 1988
1. Type-I Luminal (consisted of unilocular cystic lesions lined by
epithelium exhibiting features of ameloblastoma).
1. Type-II Intra luminal (showed epithelial nodules arising from
the cystic lining and projecting into the cyst lumen. These
nodules comprised epithelium with a plexiform or follicular
pattern resembling that seen in intraosseous ameloblastoma.).
1. Type-III Mural ameloblastoma (characterized by the presence of
invasive islands of ameloblastomatous epithelium in the
connective tissue wall of the cyst, and these islands may or may
not be connected to the cyst lining)
39. Peripheral ameloblastoma
• Peripheral ameloblastoma (PA) is a rare odontogenic tumor that
accounts for 1% for all ameloblastomas.
• Kuri first reported PA in 1911
• In 1959, Stanley and Krogh defined the clinical and histopathologic
characteristics.
• The strict definition of PA according to Buchner and Scuibba (1987)
excludes lesions in extragingival locations.
40. The etiology of PA is unclear. The tumor can derive from the extraosseous
epithelial remnants of the dental lamina or from the basal cell layer of the
oral mucosa, which is believed to have odontogenic potential
41. • The differential diagnosis usually includes
– Pyogenic granuloma, peripheral
– Giant cell granuloma,
– Peripheral odontogenic fibroma,
– Peripheral ossifying fibroma,
– Papilloma,
– Epulis.
• Only four cases of malignant PA have been
reported to date.
48. 1. Definitive & offer best cure
2. Curettage and enucleation – recurrence
3. Curettage condemned
4. Cancellous bone – readily infiltrated
resorbed by tumor
5. Dense cortical bone - temporary barriers
49. A safe margin of uninvolved bone is 2 cm for
solid and multicystic lesion
1-1.5 for unicystic and peripheral lesions
Resorption of cortical bone – periosteum
involved – surrounding soft tissue and muscle
Post treatment follow up 15-20 yrs
51. Intra osseous solid / multi cystic
ameloblastoma
Excision of lesion
Enbloc resection -- without continuity
defect
Enbloc resection– with continuity
defect
52.
53.
54. Inferior alveolar nerve if in lesion- sacrificed
Nerve grafting best to perform at time of
resection
Resection should be exterior to tumor
involving plane
55. A thin inferior border preserved may fracture-
reconstruction plate
<1 cm not practical
Resection with sharp cutting instrument
Grinding with bur – not allow histologic
evaluation at tumor bone interface
57. • Autogenous free bone graft
• Allogenic bone with reconstruction plate
• Platelet rich plasma mixed into a cortical/
cancellous bone graft
• If sufficient soft tissue not available -
vascularized composite pedicle graft
• Delayed reconstruction : reconstruction plate to
maintain resection space
58. An anatomic classification of maxillary ameloblastoma as
an aid to surgical treatment
I T Jackson and P P Callan
J Cranio Maxillofac Surg 1996;24; 230
Group I tumors confined to maxilla with out involving orbital floor
- Partial maxillectomy
Group II tumor involving orbital floor not the periorbital tissue
- total maxillectomy
Group III tumor involving orbital contents
- total maxillectomy with orbital excentration
Group IV tumor involving skull base
- total maxillectomy with orbital excentration and anterior
skull base resection
59. Unicystic ameloblastoma
Initial diagnosis
Dentigerous cyst or OKC
Enucleation or marsupialization?
Careful assessment
Biopsy may not confirm
Physical basis cleavage plane
Microscopic section R without CD or
R with CD
60. Peripheral ameloblastoma
Enmass excision
With overlying mucosa periosteum
alveolar bone and adjacent teeth
1-1.5 resection margin
62. Carnoy’ solution
• Culter & Zollinger 1933 described as a
sclerozing agent for the treatment of cysts and
fistulae, and remains in use today as a fixative
Composition
i. Glacial acetic acid
ii. Absolute alcohol
iii. Chloroform
iv. Ferric chloride
• Depth of penetration 1.5-1.8 mm
63. Unicystic ameloblastoma – use of Carnoy’s
solution after enucleation
P K Lee N Samman
Int J Oral Maxillofac Surg 2004; 33 ; 263-7
64. Cryotherapy
Adjunct to curettage
Devitalize the tissue with liquid nitrogen
Depth 1.5 cm
Jaw can be frozen the entire thickness
Complication sequestration and pathologic
fracture
Transient anesthesia
65. Management of mandibular ameloblastoma
treatment algorithm
Daniel E Sampson, M. Anthony Pogrel
J Oral Maxfac Surg 57; 1074-77 :1999
• Curettage recurrence
• Curettage with cryotherapy
• Confined to bone respond well to cryotherapy
• Soft tissue extension – necrosis
• Pathologic fracture – secondary to necrosis and
demineralization of bone
• Immediate bone grafting
66. Radiotherapy
Inoperable cases
Invasion into cranium
Primarily intraosseous- resistant
Extra osseous ameloblastoma - reduced
Possible osteoradionecrosis
Cause of metastasis
67. MALIGNANT BEHAVIOUR AND META STASIS
• Malignant ameloblastoma is a histologically well-
differentiated, benign appearing ameloblastoma with
metastatic disease histologically identical to the primary
tumor.
• Ameloblastic carcinoma is an ameloblastoma with
histological malignant transformation in the primary
lesion with or without metastatic disease.
68. • Metastases from malignant ameloblastomas have been
reported in the
– lung (75%),
– cervical lymph nodes (15%),
– spine (15%), and,
– less frequently, in the liver, skull, diaphragm, and brain.
• Markedly aggressive clinical course
• Quiescent chronicity
• After irradiation
69. Pulmonary metastasis of ameloblastoma
James M Henderson, J R Sonnet
J. Oral Surg Oral Path Oral Med Oral Radiol Endod;88 ;170-6:1999
• 41 cases metastatic to lung has been reported
• Inadequate and inappropriate treatment – recurrence
increased risk of metastasis
• Route aspiration of tumor particles/ hematogenous
spread
70. Rational approach to diagnosis and treatment of
ameloblastoma and OKC
Karen A O M Chapelle, Paul J W Stoclinge
British J Oral Maxfac Surg 42; 381-390 :2004
72. Ameloblastoma in children
R A Ord, R H Blanchaert Et Al
J Oral Maxfac Surg 60; 762-70 : 2002
Differ
Higher % unicystic and fast growing
Mural invasion
More aggressive surgery necessary
73. In discussion
Arie Shteyer suggest
1. Precise differential diagnosis
2. Conservative approach
Decompression- Iodoform gauze
soaked in whiteheads varnish
3. Long term follow up
4. recurrence extensive surgery